Viewing Study NCT00301093


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2025-12-25 @ 11:29 PM
Study NCT ID: NCT00301093
Status: COMPLETED
Last Update Posted: 2020-10-28
First Post: 2006-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module